ETF MarketETN MarketCalendarRankingComparisonContent

Home

0001P0·Stock-Sector-Healthcare

Website

Mighty Biosimilar & CDMO Active

Introduction

The Mighty Biosimilar & CDMO Active ETF aims to outperform the FnGuide Bio Similar & CDMO Index by actively adjusting weightings and selectively including non-benchmark asset in its portfolio

Investment Points

An ETF investing in leading biosimilar companies in Korea, represented by Samsung Biologics and Celltrion.

Benchmark Index

FnGuide Bio Similar & CDMO Index

Benchmark Index Description

A thematic index selectively investing in companies involved in manufacturing biosimilar drugs whose patents have expired and pharmaceutical contract (development) manufacturing companies.

Issuer

DB Asset Management CO., LTD.

Brand

마이티

Total Fee

0.81

Listing Date

2024-12-24

International Securities Code

KR70001P0004

Market Information

Market Capitalization

12,672,000,000KRW

Transaction Amount

27,673,294KRW

Trading Volume

2,780

Shares Outstanding

1,280,000

NAV

9,890

52-Week High

10,375KRW

52-Week Low

9,625KRW

HoldingsChartDividendFees and TaxesPerformance